IMS新出的报告
The Global Use of Medicines: Outlook through 2017. Report by the IMS Institute for Healthcare Informatics.
发布报告的机构名称：IMS
报告发布时间：2013
报告页数：42 pages
报告的文件格式：PDF
报告大小：1.8M


报告目录：
Contents
EXECUTIVE SUMMARY ___________________________________________________1
Global spending on medicines ________________________________________4
• Total global spending on medicines will reach about $1.2Tn in 2017,
an increase of $205-235Bn from 2012
Key countries and alternative scenarios ____________________________10
• The U.S., EU5 (the aggregate of Germany, France, Italy, U.K. and Spain), Japan and China will account
for 67% of global spending on medicines in 2017, contributing 59% of the global growth in the 5
year period to 2017.
Mix of bra nded and generic medicines _______________________________22
• The mix of total global spending on medicines will shift toward generics over the next five years,
rising from 27% to 36% of the total by 2017, even as brands will continue to account for more than
two thirds of spending in developed markets.
Tra nsformati ons in Disease Treatme nt ______________________________27
• The current pharmaceutical industry’s research and development pipeline holds the potential to
transform care across a wide range of disease areas.
Notes on Sources & DEFINITIONS _______________________________________32
Appendices ____________________________________________________________33
THE AUTHORS __________________________________________________________35
ABOUT THE IMS INSTITUTE _______________________________________________37